Wanwu Capital
万物资本
elsewhere's corpus does not cover Wanwu Capital as a subject in its own right. The bundle only contains passing mentions where Wanwu Capital appears as a co-investor or participant in deals led by other firms: it followed BlueRun Ventures and Shunwei Capital in Wisson Robotics's Pre-A+ round in 2022 , and was among the investors in Recurrent AI that later filed arbitration against Kimi founder Yang Zhilin . These references do not provide founding date, team, strategy, or assets under management for Wanwu Capital itself.
AI-generated — may contain errors, please verify.
Coverage
I think the sun will shine bright tomorrow morning | Opening Remarks
Maybe wrong, always fun.
Zean completes $40 million Series A+ round to accelerate development of myeloid cell engager pipeline | BlueRun Ventures Family
Focusing on unmet clinical needs in major disease areas such as cancer and autoimmune diseases.
Exclusive | Kimi Arbitration Settlement Fails, Zhang Yutong May Face Separate Lawsuit
The AI landscape has already shifted.
Exclusive | The Full Untold Story Beneath the Surface of "Kimi Yang Zhilin Arbitration Case"
Who saw the sixpence, and who saw the moon.
Exclusive | Kimi Founder Yang Zhilin Faces Arbitration Filed by Former Investors
Another scandal at a high-profile AI company.
Allen Zhu went left, Zhang Yutong went right
When Allen Zhu chose to stay put and ride out the storm, Zhang Yutong decided to find a new table.
In the long winter of consumption, Hongshan wants to snap its fingers and find resonance.
Sparks mark the beginning of the next cycle.
FreeS Family Funding News · May | Chicecream, ACC Super Accessories, DataPipeline, and Ganying AI Secure Funding
We also released two short videos this week — follow us to check them out.
